GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

FATE · Mar 31, 2026

FATE THERAPEUTICS INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001193125-26-220696General Corporate
Capex intensity45thOwn-history percentile · N=11
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

18.40% · OPTIONAL · VALID

Operating cash generation9thOwn-history percentile · N=11
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-2372.75% · OPTIONAL · VALID

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

-20.26% · CORE · NOT_ENOUGH_HISTORY

Operating margin27thOwn-history percentile · N=11
Evidence method

Level · gp.fundamentals.operating_margin

-2540.42% · CORE · VALID

R&D intensity91thOwn-history percentile · N=11
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

1901.69% · OPTIONAL · VALID

SBC intensity27thOwn-history percentile · N=11
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

302.46% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History9 statesHistory building
Period transition

What moved in the state?

Capex Intensity Decreased
Previous
89.57%
Current
18.40%
Delta
-71.17%
Cash Generation Decreased
Previous
-1596.21%
Current
-2372.75%
Delta
-776.54%
Growth Increased
Previous
-51.24%
Current
-20.26%
Delta
30.99%
Profitability Decreased
Previous
-2222.45%
Current
-2540.42%
Delta
-317.97%
R And D Intensity Increased
Previous
1622.46%
Current
1901.69%
Delta
279.23%
Sbc Intensity Decreased
Previous
375.02%
Current
302.46%
Delta
-72.56%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.